post-treatment management of esophageal cancers: surgical considerations stephen swisher, md phd...
TRANSCRIPT
![Page 1: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/1.jpg)
Post-treatment management of Post-treatment management of esophageal cancers:esophageal cancers:
Surgical considerationsSurgical considerations
Stephen Swisher, MD PhDStephen Swisher, MD PhDRobert F. Fly Professor of Surgical OncologyRobert F. Fly Professor of Surgical Oncology
Chairman, Department of Thoracic and Cardiovascular SurgeryChairman, Department of Thoracic and Cardiovascular SurgeryMD Anderson Cancer CenterMD Anderson Cancer Center
Houston, TXHouston, TX
![Page 2: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/2.jpg)
![Page 3: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/3.jpg)
Role of surgery for treatment of tumor recurrence afterRole of surgery for treatment of tumor recurrence after• Esophagectomy (without chemoXRT)Esophagectomy (without chemoXRT)
surgical options for recurrent tumor after primary esophagectomysurgical options for recurrent tumor after primary esophagectomy
Colon
Jejunum
![Page 4: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/4.jpg)
Role of surgery for treatment of tumor recurrence afterRole of surgery for treatment of tumor recurrence after• Esophagectomy (without chemoXRT)Esophagectomy (without chemoXRT)
surgical options for recurrent tumor after primary surgical options for recurrent tumor after primary esophagectomyesophagectomy
![Page 5: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/5.jpg)
Role of surgery for treatment of tumor recurrence afterRole of surgery for treatment of tumor recurrence after• Esophagectomy (without chemoXRT)Esophagectomy (without chemoXRT)
surgical options for recurrent tumor after primary esophagectomysurgical options for recurrent tumor after primary esophagectomy
![Page 6: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/6.jpg)
Role of surgery for treatment of tumor recurrence afterRole of surgery for treatment of tumor recurrence after• Esophagectomy (without chemoXRT)Esophagectomy (without chemoXRT)
surgical options for recurrent tumor after primary esophagectomysurgical options for recurrent tumor after primary esophagectomy
![Page 7: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/7.jpg)
Role of surgery for treatment of tumor recurrence afterRole of surgery for treatment of tumor recurrence after• Esophagectomy (without chemoXRT)Esophagectomy (without chemoXRT)
surgical options for recurrent tumor after primary surgical options for recurrent tumor after primary esophagectomyesophagectomy
![Page 8: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/8.jpg)
Role of surgery for treatment of tumor recurrence afterRole of surgery for treatment of tumor recurrence after• Definitive chemoradiationDefinitive chemoradiation
Is surgery possible after chemoradiationIs surgery possible after chemoradiation What are potential risks and benefitsWhat are potential risks and benefits
![Page 9: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/9.jpg)
Role of surgery for treatment of tumor recurrence afterRole of surgery for treatment of tumor recurrence after• Definitive chemoradiationDefinitive chemoradiation
Is surgery possible after chemoradiationIs surgery possible after chemoradiation What are potential risks and benefitsWhat are potential risks and benefits
![Page 10: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/10.jpg)
Role of surgery for treatment of tumor recurrence afterRole of surgery for treatment of tumor recurrence after• Pre-op chemo-XRT- in patients who recur after an Pre-op chemo-XRT- in patients who recur after an
complete clinical response.complete clinical response.
![Page 11: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/11.jpg)
Role of surgery for treatment of tumor recurrence afterRole of surgery for treatment of tumor recurrence after• Pre-op chemo-XRT- in patients who recur after an Pre-op chemo-XRT- in patients who recur after an
complete clinical response.complete clinical response.
![Page 12: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/12.jpg)
Role of surgery for treatment of tumor recurrence afterRole of surgery for treatment of tumor recurrence after• Pre-op chemo-XRT- in patients who recur after an Pre-op chemo-XRT- in patients who recur after an
complete clinical response.complete clinical response.
![Page 13: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/13.jpg)
Role of surgery for treatment of tumor recurrence after Role of surgery for treatment of tumor recurrence after chemoradiationchemoradiation• Salvage esophagectomy Salvage esophagectomy
What is it; Who are potential candidates; Survival benefitWhat is it; Who are potential candidates; Survival benefit
![Page 14: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/14.jpg)
Role of surgery for treatment of tumor recurrence after Role of surgery for treatment of tumor recurrence after chemoradiationchemoradiation• Salvage esophagectomy Salvage esophagectomy
What is it; Who are potential candidates; Survival benefitWhat is it; Who are potential candidates; Survival benefit
![Page 15: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/15.jpg)
Role of surgery for treatment of tumor recurrence after Role of surgery for treatment of tumor recurrence after chemoradiationchemoradiation• Salvage esophagectomy Salvage esophagectomy
What is it; Who are potential candidates; Survival benefitWhat is it; Who are potential candidates; Survival benefit
![Page 16: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/16.jpg)
Role of surgery for treatment of tumor recurrence after Role of surgery for treatment of tumor recurrence after chemoradiationchemoradiation• Salvage esophagectomy Salvage esophagectomy
What is it; Who are potential candidates; Survival benefitWhat is it; Who are potential candidates; Survival benefit
RTOG 0246RTOG 0246
![Page 17: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/17.jpg)
Role of surgery for treatment of tumor recurrence after Role of surgery for treatment of tumor recurrence after chemoradiationchemoradiation• Salvage esophagectomy Salvage esophagectomy
What is it; Who are potential candidates; Survival benefitWhat is it; Who are potential candidates; Survival benefit
![Page 18: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/18.jpg)
Role of surgery for treatment of tumor recurrence after Role of surgery for treatment of tumor recurrence after chemoradiationchemoradiation• Salvage esophagectomy Salvage esophagectomy
What is it; Who are potential candidates; Survival benefitWhat is it; Who are potential candidates; Survival benefit
RTOG 0246RTOG 0246
![Page 19: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/19.jpg)
Q1Q1
![Page 20: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/20.jpg)
• Repeat endoscopy 1 year after surgery to rule out Repeat endoscopy 1 year after surgery to rule out residual Barrett’s or dysplasiaresidual Barrett’s or dysplasia
• No CT Scan, CXR or PET scan No CT Scan, CXR or PET scan unless symptoms unless symptoms because because of low likelihood of distant mets with T1N0, LVI negativeof low likelihood of distant mets with T1N0, LVI negative
![Page 21: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/21.jpg)
• Repeat endoscopy 1 year after surgery to rule out Repeat endoscopy 1 year after surgery to rule out residual Barrett’s or dysplasiaresidual Barrett’s or dysplasia
• No CT Scan, CXR or PET scan No CT Scan, CXR or PET scan unless symptoms unless symptoms because because of low likelihood of distant mets with T1N0, LVI negativeof low likelihood of distant mets with T1N0, LVI negative
![Page 22: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/22.jpg)
Q2Q2
![Page 23: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/23.jpg)
Path CR – no diff. in relapse locationsPath CR – no diff. in relapse locations
What we do: if What we do: if no sxs no sxs - CT scan +/- EGD q6 mos x 4 then - CT scan +/- EGD q6 mos x 4 then yrly (only yrly (only asxasx group to help – LN, ? Anast Rec) group to help – LN, ? Anast Rec)
![Page 24: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/24.jpg)
Q3Q3
![Page 25: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/25.jpg)
Salvage Esophagectomy Salvage Esophagectomy • no metastatic disease, no metastatic disease, • regional LN regional LN • no other curative Rxno other curative Rx
![Page 26: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/26.jpg)
Q4Q4
![Page 27: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/27.jpg)
Since unable to tolerate surgery Since unable to tolerate surgery • few therapeutic options if few therapeutic options if AsymtomaticAsymtomatic – – • PE q 6 monthsPE q 6 months
If If symptomaticsymptomatic • studies to assess for palliative Rx –Stents, EMR, PDT, studies to assess for palliative Rx –Stents, EMR, PDT,
BrachytherapyBrachytherapy
![Page 28: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/28.jpg)
State of the ArtState of the Art
![Page 29: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/29.jpg)
Summary of today’s state of the artSummary of today’s state of the art
AsymptomaticAsymptomatic recurrences that can be helped : recurrences that can be helped : • CT Scans +/- Endoscopy q 6 mos x 4 then q yearCT Scans +/- Endoscopy q 6 mos x 4 then q year
• Anastomotic RecurrenceAnastomotic Recurrence Salvage Surgery: Colonic/Jejunal conduitSalvage Surgery: Colonic/Jejunal conduit CRTCRT
• Local/Distant LN Local/Distant LN Surgery or CRT (non-radiated area)Surgery or CRT (non-radiated area)
![Page 30: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/30.jpg)
What new modalities are on the horizon in the next 5 What new modalities are on the horizon in the next 5 years? the next 10 years?years? the next 10 years?
Novel Molecular TherapeuticsNovel Molecular Therapeutics PET Scan identification of non-responders to allow PET Scan identification of non-responders to allow
additional treatment prior to resectionadditional treatment prior to resection
![Page 31: Post-treatment management of esophageal cancers: Surgical considerations Stephen Swisher, MD PhD Robert F. Fly Professor of Surgical Oncology Chairman,](https://reader036.vdocuments.us/reader036/viewer/2022062516/56649e625503460f94b5de7e/html5/thumbnails/31.jpg)